Swayze Eric's Form 4 filing
Ionis Pharmaceuticals IncIONS · filed Oct 19, 2026
- Accession no.
- 0000874015-26-000266
- Filed
- Oct 19, 2026, 9:40 PM ET
- Trade date
- Oct 15-16, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.31K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Swayze EricCIK 0001791058 | Officer (EVP Research) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | MOption exerciseAcquired | +125 | $0.00 | $0 | 443 | Indirect | |
| Oct 16, 2026 | Common Stock | SSaleDisposed | −53 | $43.54 | −$2,307.56 | 390 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | MOption exerciseDisposed | −125 | $0.00 | $0 | 486 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.